HCM vs RDHL
HUTCHMED (China) Limited · RedHill Biopharma Ltd.
Relative return (rebased to 100)
Key stats
| Metric | HCM | RDHL |
|---|---|---|
| Price | $13.50 | $0.52 |
| Market Cap | $11.78B | $26.23B |
| P/E | 25.77 | — |
| P/B | 9.51 | — |
| P/S | 21.47 | 3260.66 |
| ROE | 36.9% | — |
| Net Margin | 83.3% | -102.8% |
| Gross Margin | — | 60.3% |
| Revenue Growth | -13.0% | 23.2% |
| Dividend Yield | — | — |
| EPS | $0.52 | -$0.00 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.